Global artificial intelligence (AI) in drug discovery market will reach $2.57 billion by 2026, growing by 30.3% annually over 2020-2026 despite the COVID-19 impact.
Highlighted with 86 tables and 86 figures, this 178-page report “Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global AI in drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global AI in drug discovery market in every aspect of the classification from perspectives of Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region.
Based on offering, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
• Software
• Service
Based on technology, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
• Deep Learning
• Supervised Learning
• Reinforcement Learning
• Unsupervised Learning
• Other Technologies
Based on drug type, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
• Large-molecule Drugs
• Small-molecular Drugs
Based on therapeutic area, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
• Oncology
• Neurodegenerative Diseases
• Cardiovascular Disease
• Metabolic Diseases
• Other Therapeutic Areas
Based on application, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
• Information & Data Analysis
• Drug Design
• Drug Evaluation
• Clinical Trials
• Other Applications
Based on end user, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations
Geographically, the following regions together with the listed national/local markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• RoW (Saudi Arabia, UAE, Egypt)
For each of the aforementioned regions and countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of all regional markets by country and split of key national markets by Technology, Therapeutic Area, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global AI in drug discovery market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Atomwise, Inc.
BenevolentAI
Berg LLC
Bioage
BIOAGE
Cloud Pharmaceuticals, Inc.
Cyclica
Deep Genomics
Envisagenics
Exscientia
Google
IBM Corporation
Insilico Medicine
Microsoft Corporation
Numedii, Inc.
Numerate
NVIDIA Corporation
Owkin, Inc.
Twoxar, Incorporated
Verge Genomics
Xtalpi, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 17
1.2.6 Market Size/Share Estimation 18
1.2.7 Research Limitations 19
1.3 Executive Summary 20
2 Market Overview and Dynamics 23
2.1 Market Size and Forecast 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 28
2.4 Emerging Opportunities and Market Trends 31
2.5 Porter’s Fiver Forces Analysis 35
3 Segmentation of Global Market by Offering 39
3.1 Market Overview by Offering 39
3.2 Software 41
3.3 Service 42
4 Segmentation of Global Market by Technology 43
4.1 Market Overview by Technology 43
4.2 Deep Learning 45
4.3 Supervised Learning 46
4.4 Reinforcement Learning 47
4.5 Unsupervised Learning 48
4.6 Other Technologies 49
5 Segmentation of Global Market by Drug Type 50
5.1 Market Overview by Drug Type 50
5.2 Large-molecule Drugs 52
5.3 Small-molecular Drugs 53
6 Segmentation of Global Market by Therapeutic Area 54
6.1 Market Overview by Therapeutic Area 54
6.2 Oncology 57
6.3 Neurodegenerative Diseases 58
6.4 Cardiovascular Disease 59
6.5 Metabolic Diseases 60
6.6 Other Therapeutic Areas 61
7 Segmentation of Global Market by Application 62
7.1 Market Overview by Application 62
7.2 Information & Data Analysis 64
7.3 Drug Design 65
7.4 Drug Evaluation 66
7.5 Clinical Trials 67
7.6 Other Applications 68
8 Segmentation of Global Market by End User 69
8.1 Market Overview by End User 69
8.2 Pharmaceutical & Biotechnology Companies 71
8.3 Academic & Research Institutes 72
8.4 Contract Research Organizations 73
9 Segmentation of Global Market by Region 74
9.1 Geographic Market Overview 2019-2026 74
9.2 North America Market 2019-2026 by Country 78
9.2.1 Overview of North America Market 78
9.2.2 U.S. 82
9.2.3 Canada 86
9.2.4 Mexico 88
9.3 European Market 2019-2026 by Country 90
9.3.1 Overview of European Market 90
9.3.2 UK 94
9.3.3 France 96
9.3.4 Germany 98
9.3.5 Spain 100
9.3.6 Italy 102
9.3.7 Russia 104
9.3.8 Rest of European Market 106
9.4 Asia-Pacific Market 2019-2026 by Country 108
9.4.1 Overview of Asia-Pacific Market 108
9.4.2 China 111
9.4.3 Japan 113
9.4.4 India 116
9.4.5 Australia 118
9.4.6 South Korea 120
9.4.7 Rest of APAC Region 122
9.5 South America Market 2019-2026 by Country 124
9.5.1 Argentina 127
9.5.2 Brazil 129
9.5.3 Chile 131
9.5.4 Rest of South America Market 133
9.6 Rest of World Market 2019-2026 by Country 134
9.6.1 UAE 137
9.6.2 Saudi Arabia 139
9.6.3 Egypt 141
9.6.4 Other National Markets 143
10 Competitive Landscape 144
10.1 Overview of Key Vendors 144
10.2 New Product Launch, Partnership, Investment, and M&A 149
10.3 Company Profiles 150
Atomwise, Inc. 150
BenevolentAI 152
Berg LLC 153
Bioage 154
BIOAGE 155
Cloud Pharmaceuticals, Inc. 156
Cyclica 157
Deep Genomics 158
Envisagenics 159
Exscientia 160
Google 161
IBM Corporation 162
Insilico Medicine 163
Microsoft Corporation 164
Numedii, Inc. 165
Numerate 166
NVIDIA Corporation 167
Owkin, Inc. 168
Twoxar, Incorporated 169
Verge Genomics 170
Xtalpi, Inc. 171
11 Investing in Global Market: Risk Assessment and Management 172
11.1 Risk Evaluation of Global Market 172
11.2 Critical Success Factors (CSFs) 175
Related Reports and Products 178
Table 1. Snapshot of Global AI in Drug Discovery Market, 2019-2026 21
Table 2. Main Product Trends and Market Opportunities in Global AI in Drug Discovery Market 31
Table 3. Global AI in Drug Discovery Market by Offering, 2015-2026, $ mn 39
Table 4. Global AI in Drug Discovery Market by Technology, 2015-2026, $ mn 43
Table 5. Global AI in Drug Discovery Market by Drug Type, 2015-2026, $ mn 50
Table 6. Global AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 54
Table 7. Selected Drug Development Pipelines Aided by AI 56
Table 8. Global AI in Drug Discovery Market by Application, 2015-2026, $ mn 62
Table 9. Global AI in Drug Discovery Market by End User, 2015-2026, $ mn 69
Table 10. Global AI in Drug Discovery Market by Region, 2015-2026, $ mn 75
Table 11. Leading National AI in Drug Discovery Market, 2019 and 2026, $ mn 77
Table 12. North America AI in Drug Discovery Market by Country, 2015-2026, $ mn 80
Table 13. U.S. AI in Drug Discovery Market by Technology, 2015-2026, $ mn 84
Table 14. U.S. AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 84
Table 15. U.S. AI in Drug Discovery Market by End User, 2015-2026, $ mn 84
Table 16. Canada AI in Drug Discovery Market by Technology, 2015-2026, $ mn 87
Table 17. Canada AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 87
Table 18. Canada AI in Drug Discovery Market by End User, 2015-2026, $ mn 87
Table 19. Mexico AI in Drug Discovery Market by Technology, 2015-2026, $ mn 89
Table 20. Mexico AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 89
Table 21. Mexico AI in Drug Discovery Market by End User, 2015-2026, $ mn 89
Table 22. Europe AI in Drug Discovery Market by Country, 2015-2026, $ mn 92
Table 23. UK AI in Drug Discovery Market by Technology, 2015-2026, $ mn 95
Table 24. UK AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 95
Table 25. UK AI in Drug Discovery Market by End User, 2015-2026, $ mn 95
Table 26. France AI in Drug Discovery Market by Technology, 2015-2026, $ mn 97
Table 27. France AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 97
Table 28. France AI in Drug Discovery Market by End User, 2015-2026, $ mn 97
Table 29. Germany AI in Drug Discovery Market by Technology, 2015-2026, $ mn 99
Table 30. Germany AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 99
Table 31. Germany AI in Drug Discovery Market by End User, 2015-2026, $ mn 99
Table 32. Spain AI in Drug Discovery Market by Technology, 2015-2026, $ mn 101
Table 33. Spain AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 101
Table 34. Spain AI in Drug Discovery Market by End User, 2015-2026, $ mn 101
Table 35. Italy AI in Drug Discovery Market by Technology, 2015-2026, $ mn 103
Table 36. Italy AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 103
Table 37. Italy AI in Drug Discovery Market by End User, 2015-2026, $ mn 103
Table 38. Russia AI in Drug Discovery Market by Technology, 2015-2026, $ mn 105
Table 39. Russia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 105
Table 40. Russia AI in Drug Discovery Market by End User, 2015-2026, $ mn 105
Table 41. AI in Drug Discovery Market in Rest of Europe by Country, 2015-2026, $ mn 107
Table 42. APAC AI in Drug Discovery Market by Country, 2015-2026, $ mn 110
Table 43. China AI in Drug Discovery Market by Technology, 2015-2026, $ mn 112
Table 44. China AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 112
Table 45. China AI in Drug Discovery Market by End User, 2015-2026, $ mn 112
Table 46. Japan AI in Drug Discovery Market by Technology, 2015-2026, $ mn 115
Table 47. Japan AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 115
Table 48. Japan AI in Drug Discovery Market by End User, 2015-2026, $ mn 115
Table 49. India AI in Drug Discovery Market by Technology, 2015-2026, $ mn 117
Table 50. India AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 117
Table 51. India AI in Drug Discovery Market by End User, 2015-2026, $ mn 117
Table 52. Australia AI in Drug Discovery Market by Technology, 2015-2026, $ mn 119
Table 53. Australia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 119
Table 54. Australia AI in Drug Discovery Market by End User, 2015-2026, $ mn 119
Table 55. South Korea AI in Drug Discovery Market by Technology, 2015-2026, $ mn 121
Table 56. South Korea AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 121
Table 57. South Korea AI in Drug Discovery Market by End User, 2015-2026, $ mn 121
Table 58. AI in Drug Discovery Market in Rest of APAC by Country, 2015-2026, $ mn 123
Table 59. South America AI in Drug Discovery Market by Country, 2015-2026, $ mn 126
Table 60. Argentina AI in Drug Discovery Market by Technology, 2015-2026, $ mn 128
Table 61. Argentina AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 128
Table 62. Argentina AI in Drug Discovery Market by End User, 2015-2026, $ mn 128
Table 63. Brazil AI in Drug Discovery Market by Technology, 2015-2026, $ mn 130
Table 64. Brazil AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 130
Table 65. Brazil AI in Drug Discovery Market by End User, 2015-2026, $ mn 130
Table 66. Chile AI in Drug Discovery Market by Technology, 2015-2026, $ mn 132
Table 67. Chile AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 132
Table 68. Chile AI in Drug Discovery Market by End User, 2015-2026, $ mn 132
Table 69. RoW AI in Drug Discovery Market by Country, 2015-2026, $ mn 136
Table 70. UAE AI in Drug Discovery Market by Technology, 2015-2026, $ mn 138
Table 71. UAE AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 138
Table 72. UAE AI in Drug Discovery Market by End User, 2015-2026, $ mn 138
Table 73. Saudi Arabia AI in Drug Discovery Market by Technology, 2015-2026, $ mn 140
Table 74. Saudi Arabia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 140
Table 75. Saudi Arabia AI in Drug Discovery Market by End User, 2015-2026, $ mn 140
Table 76. Egypt AI in Drug Discovery Market by Technology, 2015-2026, $ mn 142
Table 77. Egypt AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 142
Table 78. Egypt AI in Drug Discovery Market by End User, 2015-2026, $ mn 142
Table 79. Use Cases of AI for Drug Discovery by Selected Pharmaceutical Companies 147
Table 80. Atomwise, Inc.: Company Snapshot 150
Table 81. Atomwise, Inc.: Business Segmentation 150
Table 82. Atomwise, Inc.: Product Portfolio 151
Table 83. Atomwise, Inc.: Revenue, 2016-2018, $ mn 151
Table 84. Atomwise, Inc.: Recent Developments 151
Table 85. Risk Evaluation for Investing in Global Market, 2019-2026 173
Table 86. Critical Success Factors and Key Takeaways 176
